Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 74-77

  Wu, Darren C ^a   Ofner III, Clyde M ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

adsorption; analysis; chemical stability; doxorubicin; glass; HPLC; polypropylene

Indexed keywords

DOXORUBICIN; POLYPROPYLENE;

AQUEOUS SOLUTION; ARTICLE; CONTAINER; DRUG ADSORPTION; DRUG DEGRADATION; DRUG RELEASE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ADSORPTION; ANTINEOPLASTIC AGENTS; DOXORUBICIN; POLYPROPYLENES; SOLUTIONS; WATER;

EID: 84878524008     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9885-1     Document Type: Article

References (13)

1. Chabner BA, Bertino J, Cleary J, Ortiz T, Lane A, Supko J, et al. Cytotoxic agents. In: Brunton LL, Chabner BA, Knollman BC, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011.
2. Vigevani A, Williamson MJ. Doxorubicin. In: Florey K, editor. Analytical profiles of drug substances. New York: Academic; 1980. p. 245-72.
3. Janssen MJH, Crommelin DJA, Storm G, Hulshoff A. Doxorubicin decomposition on storage. Effect of pH, type of buffer and liposome encapsulation. Int J Pharm. 1985;23(1):1-11.
4. Beijnen JH, van der Houwen OAGJ, Underberg WJM. Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int J Pharm. 1986;32:123-31.
5. Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther. 1990;15(4):291-300. Epub 1990/08/01.
6. Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther. 1990;15(4):279-89. Epub 1990/08/01.
7. Tomlinson E, Malspeis L. Concomitant adsorption and stability of some anthracycline antibiotics. J Pharm Sci. 1982;71(10):1121-5. Epub 1982/10/01.
8. Bapat NV. Formulation and pharmacokinetics of doxorubicin associated with polymeric nanoparticles and oxidized dextran. PhD Dissertation, Northeastern University; 1991.
9. Van Hensbergen Y, Broxterman HJ, Elderkamp YW, Lankelma J, Beers JCC, Heijin M, et al. A doxorubicin-CNGRC-peptide conjugate with prodrug properties. Biochem Pharmacol. 2002;63:897-908.
10. Vora J, Bapat NV, Boroujerdi M. Investigation of the relative affinity of doxorubicin for neutral and negatively charge particulate carriers. Drug Dev Ind Pharm. 1993;19(7):759-71.
11. Wang Y, Yang ST, Wang Y, Liu Y, Wang W. Adsorption and desorption of doxorubicin on oxidized carbon nanotubes. Colloids Surf B Biointerfaces. 2012;97:62-9.
12. Miao J, Zhang F, Takieddin M, Mousa S, Linhardrt RJ. Adsorption of doxorubicin on poly(methyl methacrulate)-chitosan-heparin-coated activated carbon beads. Langmuir. 2012;28:4396-403.
13. Zutshi A. Physicochemical characterization and stability of doxorubicin in aqueous solutions. Ph.D. Dissertation, University of Florida; 1994.